Literature DB >> 30571922

Lymphangioleiomyomatosis Mortality in Patients with Tuberous Sclerosis Complex.

Sara Zak1, Nadine Mokhallati2, Weiji Su1, Francis X McCormack3, David N Franz1, Maxwell Mays1, Darcy A Krueger1, Rhonda D Szczesniak1, Nishant Gupta4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30571922      PMCID： PMC6441691          DOI： 10.1513/AnnalsATS.201807-471RL

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  21 in total

1.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.

Authors:  Hope Northrup; Darcy A Krueger
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

2.  Lymphangioleiomyomatosis and Tuberous Sclerosis Complex in Quebec: Prevalence and Health-care Utilization.

Authors:  Arnold S Kristof; Pei Zhi Li; Philippe Major; Jennifer S Landry
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

3.  Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis.

Authors:  D N Franz; A Brody; C Meyer; J Leonard; G Chuck; S Dabora; G Sethuraman; T V Colby; D J Kwiatkowski; F X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

4.  The NHLBI LAM Registry: Prognostic Physiologic and Radiologic Biomarkers Emerge From a 15-Year Prospective Longitudinal Analysis.

Authors:  Nishant Gupta; Hye-Seung Lee; Jay H Ryu; Angelo M Taveira-DaSilva; Gerald J Beck; Jar-Chi Lee; Kevin McCarthy; Geraldine A Finlay; Kevin K Brown; Stephen J Ruoss; Nilo A Avila; Joel Moss; Francis X McCormack
Journal:  Chest       Date:  2018-06-22       Impact factor: 9.410

5.  Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features.

Authors:  Nilo A Avila; Andrew J Dwyer; Antoinette Rabel; Joel Moss
Journal:  Radiology       Date:  2006-11-14       Impact factor: 11.105

6.  Lymphangioleiomyomatosis screening in women with tuberous sclerosis.

Authors:  Corey J Cudzilo; Rhonda D Szczesniak; Alan S Brody; Mantosh S Rattan; Darcy A Krueger; John J Bissler; David N Franz; Francis X McCormack; Lisa R Young
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

7.  Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

Authors:  David Neal Franz; Elena Belousova; Steven Sparagana; E Martina Bebin; Michael Frost; Rachel Kuperman; Olaf Witt; Michael H Kohrman; J Robert Flamini; Joyce Y Wu; Paolo Curatolo; Petrus J de Vries; Vicky H Whittemore; Elizabeth A Thiele; James P Ford; Gaurav Shah; Helene Cauwel; David Lebwohl; Tarek Sahmoud; Sergiusz Jozwiak
Journal:  Lancet       Date:  2012-11-14       Impact factor: 79.321

8.  Causes of death in patients with tuberous sclerosis.

Authors:  C W Shepherd; M R Gomez; J T Lie; C S Crowson
Journal:  Mayo Clin Proc       Date:  1991-08       Impact factor: 7.616

9.  TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex.

Authors:  D A Muzykewicz; A Sharma; V Muse; A L Numis; J Rajagopal; E A Thiele
Journal:  J Med Genet       Date:  2009-05-05       Impact factor: 6.318

10.  Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome.

Authors:  Patrick Royston; Mahesh K B Parmar
Journal:  BMC Med Res Methodol       Date:  2013-12-07       Impact factor: 4.615
View more
  3 in total

1.  Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.

Authors:  Nishant Gupta; Hye-Seung Lee; Lisa R Young; Charlie Strange; Joel Moss; Lianne G Singer; Koh Nakata; Alan F Barker; Jeffrey T Chapman; Mark L Brantly; James M Stocks; Kevin K Brown; Joseph P Lynch; Hilary J Goldberg; Gregory P Downey; Angelo M Taveira-DaSilva; Jeffrey P Krischer; Kenneth Setchell; Bruce C Trapnell; Yoshikazu Inoue; Francis X McCormack
Journal:  Eur Respir J       Date:  2019-04-04       Impact factor: 16.671

Review 2.  A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC).

Authors:  Johann Philipp Zöllner; David Neal Franz; Christoph Hertzberg; Rima Nabbout; Felix Rosenow; Matthias Sauter; Susanne Schubert-Bast; Adelheid Wiemer-Kruel; Adam Strzelczyk
Journal:  Orphanet J Rare Dis       Date:  2020-01-21       Impact factor: 4.123

3.  A population-based study to estimate survival and standardized mortality of tuberous sclerosis complex (TSC) in Taiwan.

Authors:  Jui-Hui Peng; Hung-Pin Tu; Chien-Hui Hong
Journal:  Orphanet J Rare Dis       Date:  2021-08-03       Impact factor: 4.123
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.